1. Abrogation of MAPK and Akt Signaling by AEE788 Synergistically Potentiates Histone Deacetylase Inhibitor-Induced Apoptosis through Reactive Oxygen Species Generation
   Chunrong Yu et al, 2007, Clinical Cancer Research CrossRef
2. p53 and p21 Determine the Sensitivity of Noscapine-Induced Apoptosis in Colon Cancer Cells
   Ritu Aneja et al, 2007, Cancer Research CrossRef
3. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571
   Chunrong Yu et al, 2003, Blood CrossRef
4. The Histone Deacetylase Inhibitor MS-275 Interacts Synergistically with Fludarabine to Induce Apoptosis in Human Leukemia Cells
   Sonia C. Maggio et al, 2004, Cancer Research CrossRef
5. Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactions
   Roberto R. Rosato et al, 2007, Molecular Cancer Therapeutics CrossRef
6. NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma
   Laurence Catley et al, 2003, Blood CrossRef
7. Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation
   Nadia Gurvich et al, 2004, Cancer Research CrossRef
8. Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas
   Michal Entin-Meer et al, 2005, Molecular Cancer Therapeutics CrossRef
9. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2–related protein Bad
   Kevin A. Strait et al, 2005, Molecular Cancer Therapeutics CrossRef
10. Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions
    Roberto R. Rosato et al, 2008, Molecular Cancer Therapeutics CrossRef
11. Tbx2 Is Overexpressed and Plays an Important Role in Maintaining Proliferation and Suppression of Senescence in Melanomas
    Keith W. Vance et al, 2005, Cancer Research CrossRef
12. Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies
    Kapil N. Bhalla, 2005, Journal of Clinical Oncology CrossRef
13. Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells
    Roberto R. Rosato et al, 2005, Molecular Cancer Therapeutics CrossRef
14. Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275
    Ilker Y. Eyüpoglu et al, 2006, Molecular Cancer Therapeutics CrossRef